Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07431593 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications

Study acronym: SIMO-PRO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Start date: Feb 2, 2026 to Apr 2026
    • Primary completion pushed from Feb 28, 2027 to Apr 28, 2027
    • Study sites: 0 to 1
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Rijeka
10 trials monitored
See 1 trial at risk
Obesity
3,874 trials monitored
See 152 trials at risk
This observational study aims to evaluate the diagnostic and prognostic value of the systemic immune-inflammatory index (SII) and the systemic inflammation response index (SIRI) in individuals with overweight or obesity. The study will assess their association with obesity status, metabolic complications, lifestyle patterns, dietary indices, and established inflammatory biomarkers. Participants will undergo anthropometric assessment, laboratory testing, dietary evaluation, and follow-up for response to different obesity treatment modalities over 3 years. The study intends to determine whether SII and SIRI can serve as clinically useful predictors of metabolic risk and treatment outcomes of obesity.
Trial Details
NCT Number NCT07431593
Lead Sponsor University of Rijeka
Conditions
(from sponsor)		 Overweight and Obesity, Inflammation, Metabolic Syndrome
Related terms Inflammation, Metabolic Syndrome, Obesity, Overweight
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov